Market research
4507.TSE Shionogi & Co., Ltd
TSE JPY Healthcare
Latest close
As of 30 Oct 2026
Test a moving-average rule with historical data.
Market facts
- Market cap
- 3T
- P/E ratio
- 9.81
- Analyst target
- 3354.5454
- Dividend yield
- 2.3%
- Beta
- 0.07
Profile
Instrument facts
- Exchange
- TSE
- Currency
- JPY
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- ISIN
- JP3347200002
- Market cap
- 3T
- P/E ratio
- 9.81
- Analyst target
- 3354.5454
- Dividend yield
- 2.3%
- Beta
- 0.07
About
About Shionogi & Co., Ltd
Shionogi & Co., Ltd. engages in the research, development, manufacture, and distribution of pharmaceuticals, diagnostic reagents, and medical devices in Japan and internationally. It is also involved in consumer healthcare business; manufacturing, sale, analytical testing, and pharmaceutical engineering of medicinal drugs and investigational drugs; contracted monitoring of epidemiological components in sewage; promotion of implementation in social infrastructure; and business related to providing data and information; develops and sells foothold; and research and development of mucosal vaccines. In addition, the company provides contract support services for experimental research; contract testing of agricultural production materials; solutions for education and healthcare, system development, human resource development, and training business; marketing support services; and IT services for medical and healthcare-related issues. The company was formerly known as Shionogi Shoten Co., Ltd. and changed its name to Shionogi & Co., Ltd. in 1943. The company was founded in 1878 and is headquartered in Kita, Japan.
Research context
Shionogi & Co., Ltd appears in PyInvesting’s Tokyo Stock catalogue. The price history above describes this recorded instrument; it does not by itself identify a company’s business or establish a continuous investment return.
- Currency
- JPY
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
These are the latest stored catalogue classifications, not a historical classification snapshot. An issuer description, classification effective date or currency may be unavailable. Check the issuer’s own disclosures and the observation dates before using these fields for research.
Review backtest assumptions and evidence before treating a chart or stored history as a research result.
Community
Investor discussion
1 comment
Sign in to join the 4507.TSE discussion.
5 years, 7 months ago
Shionogi & Co., Ltd is currently in a long term uptrend where the price is trading 2.8% above its 200 day moving average.
From a valuation standpoint, the stock is 91.5% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 6.0.
Shionogi & Co., Ltd's total revenue sank by 18.0% to $76B since the same quarter in the previous year.
Its net income has dropped by 6.5% to $37B since the same quarter in the previous year.
Finally, its free cash flow fell by 42.7% to $6B since the same quarter in the previous year.
Based on the above factors, Shionogi & Co., Ltd gets an overall score of 2/5.